News From The Cdex Website: Blueprint for implementing USP chapter 797 for compounding sterile preparations
American Journal of Health-System Pharmacy Eric S. Kastango
ERICS. KASTANGO, M.B.A., B.S.PHARM., FASHP, is President, Clinical IQ, LLC, 184 Columbia Turnpike #282, Florham Park, NJ (ekastango@clinicaliq.com). Excerpt relating to CDEX:
Emerging compounding and testing technology
Meeting the compounding demand for CSPs has been extremely difficult. With the requirements of USP chapter 797, many pharmacists are looking for advances in engineering controls and compounding technology to make compounding sterile preparations easier, quicker, and safer. Necessity is the mother of innovation, and companies are rising to the challenge in an effort to assist pharmacists.
Emerging testing technology. A new end-preparation testing system, ValiMed Regulatory Compliance Solution (CBEX, Rockville, MD), comprises three distinct components: the instrument, a proprietary library of chemical "fingerprints," and proprietary process automation software. It was designed to reduce errors in medication selection and the preparation of sterile compounds of admixtures, deter inadvertent substitutions, and prevent mislabeling of the medication.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.